Article
Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors.
medRxiv · 2021 · Dawson, J. C.; Munro, A.; Macleod, K.; Muir, M.; Timpson, P.; Williams, R.; Frame, M. C.; Brunton, V.; Carragher, N. O.
Key facts
| Title | Pathway profiling of a novel SRC inhibitor, AZD0424, in combination with MEK inhibitors. |
|---|---|
| First author | Dawson, J. C.; Munro, A.; Macleod, K.; Muir, M.; Timpson, P.; Williams, R.; Frame, M. C.; Brunton, V.; Carragher, N. O. |
| Journal | medRxiv |
| Published | Aug 29, 2021 |
| DOI | 10.1101/2021.08.27.457893 |
| Devices mentioned | K040782, K042884 |
| Product codes mentioned | JAK, MXZ, KPA, MYA, NJT, NKF, NQF |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1